| human | Q5 |
| P6178 | Dimensions author ID | 01005236242.27 |
| P11724 | IRIS UNISR author ID | 00153 |
| P496 | ORCID iD | 0000-0003-3976-9696 |
| P1153 | Scopus author ID | 7004391832 |
| P69 | educated at | University of Milan | Q46210 |
| University of Sassari | Q532822 | ||
| University of Maryland, Baltimore | Q4119470 | ||
| P108 | employer | San Raffaele Hospital | Q3145229 |
| Vita-Salute San Raffaele University | Q3551506 | ||
| Azienda ospedaliero universitaria di Sassari | Q43896331 | ||
| P734 | family name | Manunta | Q101040718 |
| Manunta | Q101040718 | ||
| Manunta | Q101040718 | ||
| P735 | given name | Paolo | Q15731774 |
| Paolo | Q15731774 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q47831139 | A functional common polymorphism of the ABCB1 gene is associated with chronic kidney disease and hypertension in Chinese. |
| Q36444721 | A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementia |
| Q36418073 | A new antihypertensive agent that antagonizes the prohypertensive effect of endogenous ouabain and adducin |
| Q34354207 | A new clinical multivariable model that predicts postoperative acute kidney injury: impact of endogenous ouabain |
| Q39161987 | A principal component meta-analysis on multiple anthropometric traits identifies novel loci for body shape |
| Q57397144 | ACE and α-Adducin Polymorphism as Markers of Individual Response to Diuretic Therapy |
| Q33362225 | ADDing a piece to the puzzle of cognition in schizophrenia. |
| Q47789254 | Adducin in essential hypertension |
| Q36804402 | Adducin polymorphisms and the treatment of hypertension |
| Q57397139 | Adducin, Renal Intermediate Phenotypes, and Hypertension |
| Q42792540 | Adducin- and ouabain-related gene variants predict the antihypertensive activity of rostafuroxin, part 2: clinical studies |
| Q42455933 | Alpha-adducin polymorphisms and renal sodium handling in essential hypertensive patients. |
| Q40142267 | Angiotensin-converting enzyme I/D and alpha-adducin Gly460Trp polymorphisms: from angiotensin-converting enzyme activity to cardiovascular outcome |
| Q57085383 | Are Retinal Microvascular Phenotypes Associated With the 1675G/A Polymorphism in the Angiotensin II Type-2 Receptor Gene? |
| Q57397148 | Are the new single nucleotide polymorphisms (SNPs) relevant for hypertensive populations? |
| Q48873477 | Arterial properties in relation to genetic variation in alpha-adducin and the renin-angiotensin system in a White population |
| Q48873731 | Arterial properties in relation to genetic variations in the adducin subunits in a white population |
| Q57085502 | Association Between Arterial Properties and Renal Sodium Handling in a General Population |
| Q48459991 | Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. |
| Q44525650 | Association of echocardiographic left ventricular structure with the ACE D/I polymorphism: a meta-analysis |
| Q91045562 | Associations of autozygosity with a broad range of human phenotypes |
| Q85314985 | Beta-adducin and sodium-calcium exchanger 1 gene variants are associated with systemic lupus erythematosus and lupus nephritis |
| Q46930761 | Cardiac glycosides and cardiomyopathy |
| Q39213058 | Changes in mass and energy transfer between the canopy and the atmosphere: model development and testing with a free-air CO2 enrichment (FACE) experiment |
| Q47764616 | Clinical impact of adducin polymorphism |
| Q34629401 | Common genetic variants and haplotypes in renal CLCNKA gene are associated to salt-sensitive hypertension |
| Q30558974 | Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression |
| Q35795828 | Coronary risk in relation to genetic variation in MEOX2 and TCF15 in a Flemish population |
| Q34807118 | Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. |
| Q39514878 | Deciphering Variability of PKD1 and PKD2 in an Italian Cohort of 643 Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD). |
| Q34441746 | Defining the role of common variation in the genomic and biological architecture of adult human height |
| Q44838775 | Different effects of marinobufagenin and endogenous ouabain |
| Q46417707 | Effect of weight loss through laparoscopic gastric banding on blood pressure, plasma renin activity and aldosterone levels in morbid obesity |
| Q57397183 | Efficacy and tolerability of doxazosin alone or in combination with chlorthalidone in essential hypertension |
| Q57397061 | Endogenous Ouabain and Related Genes in the Translation from Hypertension to Renal Diseases |
| Q40272490 | Endogenous Ouabain: An Old Cardiotonic Steroid as a New Biomarker of Heart Failure and a Predictor of Mortality after Cardiac Surgery. |
| Q35541172 | Endogenous cardiotonic steroids in kidney failure: a review and an hypothesis |
| Q88000592 | Endogenous ouabain and aldosterone are coelevated in the circulation of patients with essential hypertension |
| Q34723285 | Endogenous ouabain and cardiomyopathy in dialysis patients |
| Q57397152 | Endogenous ouabain and hemodynamic and left ventricular geometric patterns in essential hypertension |
| Q36464607 | Endogenous ouabain and the renin-angiotensin-aldosterone system: distinct effects on Na handling and blood pressure in human hypertension |
| Q51801144 | Endogenous ouabain in Ménière's disease. |
| Q37339599 | Endogenous ouabain in cardiovascular function and disease |
| Q36454313 | Endogenous ouabain in renal Na(+) handling and related diseases |
| Q41052610 | Endogenous ouabain, sodium balance and blood pressure: a review and a hypothesis |
| Q34802272 | Endogenous ouabain: a link between sodium intake and hypertension |
| Q33900350 | Genes involved in vasoconstriction and vasodilation system affect salt-sensitive hypertension. |
| Q38883998 | Genetic association study of exfoliation syndrome identifies a protective rare variant at LOXL1 and five new susceptibility loci. |
| Q45381521 | Genetic burden of common variants in progressive and bout-onset multiple sclerosis |
| Q57661758 | Genetic evidence of assortative mating in humans |
| Q37633874 | Genetic susceptibility variants for lung cancer: replication study and assessment as expression quantitative trait loci. |
| Q35017118 | Genetics of essential hypertension: from families to genes |
| Q39193364 | Genetics of ion homeostasis in Ménière's Disease. |
| Q37728638 | Genetics of primary hypertension: the clinical impact of adducin polymorphisms. |
| Q38801250 | Genome-Wide and Gene-Based Meta-Analyses Identify Novel Loci Influencing Blood Pressure Response to Hydrochlorothiazide. |
| Q28943288 | Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture |
| Q35737993 | Genomewide association study using a high-density single nucleotide polymorphism array and case-control design identifies a novel essential hypertension susceptibility locus in the promoter region of endothelial NO synthase |
| Q37192199 | Genomic association analysis of common variants influencing antihypertensive response to hydrochlorothiazide |
| Q30310235 | Genotyping of essential hypertension single-nucleotide polymorphisms by a homogeneous PCR method with universal energy transfer primers. |
| Q38288775 | Gly460Trp alpha-adducin mutation as a possible mechanism leading to endolymphatic hydrops in Ménière's syndrome. |
| Q30620364 | Heat wave hazard classification and risk assessment using artificial intelligence fuzzy logic |
| Q91418888 | Hypertension in High School Students: Genetic and Environmental Factors: The HYGEF Study |
| Q57397180 | Immunoreactive endogenous ouabain primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels |
| Q57085312 | Inactive Matrix Gla Protein Is Causally Related to Adverse Health Outcomes |
| Q57397131 | Independent and incremental prognostic value of endogenous ouabain in idiopathic dilated cardiomyopathy |
| Q57177158 | Ion Channels and Transporters in Inflammation: Special Focus on TRP Channels and TRPC6 |
| Q93011317 | Klotho Gene in Human Salt-Sensitive Hypertension |
| Q36463905 | Lanosterol Synthase Gene Polymorphisms and Changes in Endogenous Ouabain in the Response to Low Sodium Intake. |
| Q91123102 | Lanosterol Synthase Genetic Variants, Endogenous Ouabain, and Both Acute and Chronic Kidney Injury |
| Q57397115 | Left ventricular geometry and endogenous ouabain in a Flemish population |
| Q54407387 | Left ventricular radial function associated with genetic variation in the cGMP-dependent protein kinase. |
| Q53164373 | Left ventricular structure and function in relation to steroid biosynthesis genes in a white population. |
| Q35611114 | Low-salt diet and diuretic effect on blood pressure and organ damage |
| Q50755244 | MPO antibody-positive vasculitis in a patient with psoriatic arthritis and gold-induced membranous glomerulonephritis. |
| Q34540811 | Main results of the ouabain and adducin for Specific Intervention on Sodium in Hypertension Trial (OASIS-HT): a randomized placebo-controlled phase-2 dose-finding study of rostafuroxin |
| Q37457210 | MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma. |
| Q57397142 | Na+, kidney, hypertension and genes |
| Q46737659 | OASIS-HT: design of a pharmacogenomic dose-finding study |
| Q41613924 | Ouabain Contributes to Kidney Damage in a Rat Model of Renal Ischemia-Reperfusion Injury |
| Q33886690 | Ouabain-like factor: is this the natriuretic hormone? |
| Q38749985 | Personalized Therapy of Hypertension: the Past and the Future |
| Q36432048 | Pharmacogenomics and pharmacogenetics of hypertension: update and perspectives--the adducin paradigm |
| Q103822249 | Pharmacological blockade of TNFα prevents sarcopenia and prolongs survival in aging mice |
| Q57397121 | Physiological Interaction Between α-Adducin and WNK1-NEDD4L Pathways on Sodium-Related Blood Pressure Regulation |
| Q28238039 | Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension |
| Q37951650 | Polymorphisms, hypertension and thiazide diuretics. |
| Q38669818 | Predicting acute kidney injury: current status and future challenges |
| Q37149644 | Preoperative endogenous ouabain predicts acute kidney injury in cardiac surgery patients |
| Q33759171 | Pseudoexfoliation syndrome-associated genetic variants affect transcription factor binding and alternative splicing of LOXL1. |
| Q36250869 | Quantitative proteomics reveals novel therapeutic and diagnostic markers in hypertension. |
| Q57397182 | Recognition of markers of response to potassium-canrenoate in essential hypertension |
| Q36456452 | Relationships among endogenous ouabain, alpha-adducin polymorphisms and renal sodium handling in primary hypertension. |
| Q64275667 | Reply: "Comment on: Endogenous Ouabain and Related Genes in the Translation from Hypertension to Renal Diseases" |
| Q28235569 | Role of the adducin family genes in human essential hypertension |
| Q53022991 | Rostafuroxin protects from podocyte injury and proteinuria induced by adducin genetic variants and ouabain. |
| Q48810586 | SIK1 localizes with nephrin in glomerular podocytes and its polymorphism predicts kidney injury. |
| Q38951008 | Salt Sensitivity: Challenging and Controversial Phenotype of Primary Hypertension |
| Q46935354 | Salt intake and depletion increase circulating levels of endogenous ouabain in normal men. |
| Q44519432 | Salt, endogenous ouabain and blood pressure interactions in the general population |
| Q36456067 | Steroid biosynthesis and renal excretion in human essential hypertension: association with blood pressure and endogenous ouabain. |
| Q57397161 | Synergistic effect of α-adducin and ACE genes causes blood pressure changes with body sodium and volume expansion |
| Q35794752 | TET2 and CSMD1 genes affect SBP response to hydrochlorothiazide in never-treated essential hypertensives. |
| Q41152755 | TRPC6 gene variants and neuropsychiatric lupus. |
| Q44231755 | Target sequencing, cell experiments, and a population study establish endothelial nitric oxide synthase (eNOS) gene as hypertension susceptibility gene |
| Q40271139 | Targeting Ouabain- and Adducin-dependent mechanisms of hypertension and cardiovascular remodeling as a novel pharmacological approach |
| Q43467250 | The -665 C>T polymorphism in the eNOS gene predicts cardiovascular mortality and morbidity in white Europeans |
| Q58119707 | The TRPC6 intronic polymorphism, associated with the risk of neurological disorders in systemic lupus erythematous, influences immune cell function |
| Q37792129 | The clinical pathway for hypertensive patient of local health unit, hospitals and general practitioners, the Milan experience |
| Q36170272 | The endogenous ouabain: molecular basis of its role in hypertension and cardiovascular complications |
| Q40275184 | The risk of nephrolithiasis is causally related to inactive matrix Gla protein, a marker of vitamin K status: a Mendelian randomization study in a Flemish population |
| Q57397169 | The role of adducin in hypertension |
| Q57397174 | The young girl with renovascular hypertension of unknown origin |
| Q36987790 | Urinary neutrophil gelatinase-associated lipocalin time course during cardiac surgery. |
| Q40589901 | Xanthine oxidase gene variants and their association with blood pressure and incident hypertension: a population study |
| Q93083163 | [Psychological Assessment of a sample of women with ADPKD: quality of life, body image, anxiety and depression] |
| Q33706716 | alpha- and beta-Adducin polymorphisms affect podocyte proteins and proteinuria in rodents and decline of renal function in human IgA nephropathy |
| Q54407389 | cGMP-dependent protein kinase 1 polymorphisms underlie renal sodium handling impairment. |
Search more.